[Lung cancer screening with low dose CT requires careful consideration].
Ugeskr Laeger
; 176(42)2014 Oct 13.
Article
en Da
| MEDLINE
| ID: mdl-25316363
Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tamizaje Masivo
/
Neoplasias Pulmonares
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
Da
Revista:
Ugeskr Laeger
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Dinamarca